GFAT1 phosphorylation by AMPK promotes VEGF-induced angiogenesis

Biochemical Journal

Volumn 474, Issue 6, 2017, Pages 983-1001

  Zibrova, Darya ^a   Vandermoere, Franck ^b   Göransson, Olga ^c   Peggie, Mark ^d   Mariño, Karina V ^e   Knierim, Anne ^a   Spengler, Katrin ^a   Weigert, Cora ^f,g   Viollet, Benoit ^h,i   Morrice, Nicholas A ^j   Sakamoto, Kei ^d,k   Heller, Regine ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b UNIV MONTPELLIER   (France)

^c LUND UNIVERSITY   (Sweden)

^d UNIVERSITY OF DUNDEE   (United Kingdom)

^e Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^f UNIVERSITY OF TÜBINGEN   (Germany)

^g GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

^h INSTITUT COCHIN   (France)

ⁱ UNIVERSITÉ PARIS DESCARTES   (France)

^j Phoenix House   (United States)

^k NESTLÉ RESEARCH CENTER   (Switzerland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; GLUTAMINE FRUCTOSE 6 PHOSPHATE AMINOTRANSFERASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; SMALL INTERFERING RNA; VASCULOTROPIN; 5 AMINO 4 IMIDAZOLECARBOXAMIDE; AICA RIBONUCLEOTIDE; ALANINE; GFPT1 PROTEIN, HUMAN; GLUCOSE; HEXOSAMINE; N ACETYLGLUCOSAMINE; PHOSPHOPROTEIN; RIBONUCLEOTIDE; SERINE; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; BIOCHEMICAL ANALYSIS; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; PHOSPHOPROTEOMICS; PRIORITY JOURNAL; AMINO ACID SUBSTITUTION; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; FIBROBLAST; GENETICS; METABOLISM; PHOSPHORYLATION; PRIMARY CELL CULTURE; PROTEIN PROCESSING; UMBILICAL VEIN ENDOTHELIAL CELL;

ACETYLGLUCOSAMINE; ALANINE; AMINO ACID SUBSTITUTION; AMINOIMIDAZOLE CARBOXAMIDE; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; FIBROBLASTS; GLUCOSE; GLUTAMINE-FRUCTOSE-6-PHOSPHATE TRANSAMINASE (ISOMERIZING); HEXOSAMINES; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; PHOSPHOPROTEINS; PHOSPHORYLATION; PRIMARY CELL CULTURE; PROTEIN PROCESSING, POST-TRANSLATIONAL; RIBONUCLEOTIDES; RNA, SMALL INTERFERING; SERINE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 85016157569     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BCJ20160980     Document Type: Article

References (53)

1. Steinberg, G.R. and Kemp, B.E. (2009) AMPK in health and disease. Physiol. Rev. 89, 1025-1078 doi:10.1152/physrev.00011.2008
2. Scott, J.W., Ling, N., Issa, S.M.A., Dite, T.A., O'Brien, M.T., Chen, Z.-P. et al. (2014) Small molecule drug A-769662 and AMP synergistically activate naive AMPK independent of upstream kinase signaling. Chem. Biol. 21, 619-627 doi:10.1016/j.chembiol.2014.03.006
3. Xiao, B., Sanders, M.J., Underwood, E., Heath, R., Mayer, F.V., Carmena, D. et al. (2011) Structure of mammalian AMPK and its regulation by ADP. Nature 472, 230-233 doi:10.1038/nature09932
4. Gowans, G.J., Hawley, S.A., Ross, F.A. and Hardie, D.G. (2013) AMP is a true physiological regulator of AMP-activated protein kinase by both allosteric activation and enhancing net phosphorylation. Cell Metab. 18, 556-566 doi:10.1016/j.cmet.2013.08.019
5. Merrill, G.F., Kurth, E.J., Hardie, D.G. and Winder, W.W. (1997) AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. Am. J. Physiol. 273, E1107-E1112 PMID:9435525
6. Munday, M.R., Campbell, D.G., Carling, D. and Hardie, D.G. (1988) Identification by amino acid sequencing of three major regulatory phosphorylation sites on rat acetyl-CoA carboxylase. Eur. J. Biochem. 175, 331-338 doi:10.1111/j.1432-1033.1988.tb14201.x
7. Gwinn, D.M., Shackelford, D.B., Egan, D.F., Mihaylova, M.M., Mery, A., Vasquez, D.S. et al. (2008) AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol. Cell 30, 214-226 doi:10.1016/j.molcel.2008.03.003
8. Inoki, K., Zhu, T. and Guan, K.-L. (2003) TSC2 mediates cellular energy response to control cell growth and survival. Cell 115, 577-590 doi:10.1016/S0092-8674(03)00929-2
9. Fisslthaler, B. and Fleming, I. (2009) Activation and signaling by the AMP-activated protein kinase in endothelial cells. Circ. Res. 105, 114-127 doi:10.1161/CIRCRESAHA.109.201590
10. Stahmann, N., Woods, A., Spengler, K., Heslegrave, A., Bauer, R., Krause, S. et al. (2010) Activation of AMP-activated protein kinase by vascular endothelial growth factor mediates endothelial angiogenesis independently of nitric-oxide synthase. J. Biol. Chem. 285, 10638-10652 doi:10.1074/jbc.M110.108688
11. Oki, T., Yamazaki, K., Kuromitsu, J., Okada, M. and Tanaka, I. (1999) cDNA cloning and mapping of a novel subtype of glutamine: fructose-6-phosphate amidotransferase (GFAT2) in human and mouse. Genomics 57, 227-234 doi:10.1006/geno.1999.5785
12. Eguchi, S., Oshiro, N., Miyamoto, T., Yoshino, K.-i, Okamoto, S., Ono, T. et al. (2009) AMP-activated protein kinase phosphorylates glutamine: fructose-6-phosphate amidotransferase 1 at Ser243 to modulate its enzymatic activity. Genes Cells 14, 179-189 doi:10.1111/j.1365-2443.2008.01260.x
13. Li, Y., Roux, C., Lazereg, S., LeCaer, J.-P., Laprévote, O., Badet, B. et al. (2007) Identification of a novel serine phosphorylation site in human glutamine: fructose-6-phosphate amidotransferase isoform 1. Biochemistry 46, 13163-13169 doi:10.1021/bi700694c
14. Banko, M.R., Allen, J.J., Schaffer, B.E., Wilker, E.W., Tsou, P., White, J.L. et al. (2011) Chemical genetic screen for AMPKα2 substrates uncovers a network of proteins involved in mitosis. Mol. Cell 44, 878-892 doi:10.1016/j.molcel.2011.11.005
15. Hardivillé, S. and Hart, G.W. (2014) Nutrient regulation of signaling, transcription, and cell physiology by O-GlcNAcylation. Cell Metab. 20, 208-213 doi:10.1016/j.cmet.2014.07.014
16. Cooksey, R.C., Hebert, Jr, L.F., Zhu, J.H., Wofford, P., Garvey, W.T. and McClain, D.A. (1999) Mechanism of hexosamine-induced insulin resistance in transgenic mice overexpressing glutamine: fructose-6-phosphate amidotransferase: decreased glucose transporter GLUT4 translocation and reversal by treatment with thiazolidinedione. Endocrinology 140, 1151-1157 doi:10.1210/endo.140.3.6563
17. Hazel, M., Cooksey, R.C., Jones, D., Parker, G., Neidigh, J.L., Witherbee, B. et al. (2004) Activation of the hexosamine signaling pathway in adipose tissue results in decreased serum adiponectin and skeletal muscle insulin resistance. Endocrinology 145, 2118-2128 doi:10.1210/en.2003-0812
18. Hebert, Jr, L.F., Daniels, M.C., Zhou, J., Crook, E.D., Turner, R.L., Simmons, S.T. et al. (1996) Overexpression of glutamine: fructose-6-phosphate amidotransferase in transgenic mice leads to insulin resistance. J. Clin. Invest. 98, 930-936 doi:10.1172/JCI118876
19. Srinivasan, V., Sandhya, N., Sampathkumar, R., Farooq, S., Mohan, V. and Balasubramanyam, M. (2007) Glutamine fructose-6-phosphate amidotransferase (GFAT) gene expression and activity in patients with type 2 diabetes: inter-relationships with hyperglycaemia and oxidative stress. Clin. Biochem. 40, 952-957 doi:10.1016/j.clinbiochem.2007.05.002
20. Ma, J. and Hart, G.W. (2013) Protein O-GlcNAcylation in diabetes and diabetic complications. Expert Rev. Proteomics 10, 365-380 doi:10.1586/14789450.2013.820536
21. Laczy, B., Hill, B.G., Wang, K., Paterson, A.J., White, C.R., Xing, D. et al. (2009) Protein O-GlcNAcylation: a new signaling paradigm for the cardiovascular system. Am. J. Physiol. Heart Circ. Physiol. 296, H13-H28 doi:10.1152/ajpheart.01056.2008
22. Goransson, O., McBride, A., Hawley, S.A., Ross, F.A., Shpiro, N., Foretz, M. et al. (2007) Mechanism of action of A-769662, a valuable tool for activation of AMP-activated protein kinase. J. Biol. Chem. 282, 32549-32560 doi:10.1074/jbc.M706536200
23. Weigert, C., Klopfer, K., Kausch, C., Brodbeck, K., Stumvoll, M., Haring, H.U. et al. (2003) Palmitate-induced activation of the hexosamine pathway in human myotubes: increased expression of glutamine: fructose-6-phosphate aminotransferase. Diabetes 52, 650-656 doi:10.2337/diabetes.52.3.650
24. Jokela, T.A., Makkonen, K.M., Oikari, S., Karna, R., Koli, E., Hart, G.W. et al. (2011) Cellular content of UDP-N-acetylhexosamines controls hyaluronan synthase 2 expression and correlates with O-linked N-acetylglucosamine modification of transcription factors YY1 and SP1. J. Biol. Chem. 286, 33632-33640 doi:10.1074/jbc.M111.265637
25. Laderoute, K.R., Amin, K., Calaoagan, J.M., Knapp, M., Le, T., Orduna, J. et al. (2006) 50-AMP-activated protein kinase (AMPK) is induced by low-oxygen and glucose deprivation conditions found in solid-tumor microenvironments. Mol. Cell Biol. 26, 5336-5347 doi:10.1128/MCB.00166-06
26. Towler, M.C. and Hardie, D.G. (2007) AMP-activated protein kinase in metabolic control and insulin signaling. Circ. Res. 100, 328-341 doi:10.1161/01.RES.0000256090.42690.05
27. Heller, R., Unbehaun, A., Schellenberg, B., Mayer, B., Werner-Felmayer, G. and Werner, E.R. (2001) L-ascorbic acid potentiates endothelial nitric oxide synthesis via a chemical stabilization of tetrahydrobiopterin. J. Biol. Chem. 276, 40-47 doi:10.1074/jbc.M004392200
28. Reihill, J.A., Ewart, M.-A., Hardie, D.G. and Salt, I.P. (2007) AMP-activated protein kinase mediates VEGF-stimulated endothelial NO production. Biochem. Biophys. Res. Commun. 354, 1084-1088 doi:10.1016/j.bbrc.2007.01.110
29. Kommaddi, R.P., Dickson, K.M. and Barker, P.A. (2011) Stress-induced expression of the p75 neurotrophin receptor is regulated by O-GlcNAcylation of the Sp1 transcription factor. J. Neurochem. 116, 396-405 doi:10.1111/j.1471-4159.2010.07120.x
30. Ostrowski, A. and van Aalten, D.M. (2013) Chemical tools to probe cellular O-GlcNAc signalling. Biochem. J. 456, 1-12 doi:10.1042/BJ20131081
31. Broschat, K.O., Gorka, C., Page, J.D., Martin-Berger, C.L., Davies, M.S., Huang Hc, H.C. et al. (2002) Kinetic characterization of human glutamine-fructose-6-phosphate amidotransferase I: potent feedback inhibition by glucosamine 6-phosphate. J. Biol. Chem. 277, 14764-14770 doi:10.1074/jbc.M201056200
32. Badet, B., Vermoote, P., Haumont, P. Y., Lederer, F. and Le Goffic, F. (1987) Glucosamine synthetase from Escherichia coli: purification, properties, and glutamine-utilizing site location. Biochemistry 26, 1940-1948 doi:10.1021/bi00381a023
33. 2+/calmodulin-dependent protein kinase kinaseβ. Mol. Cell. Biol. 26, 5933-5945 doi:10.1128/MCB.00383-06
34. Weigert, C., Brodbeck, K., Lehmann, R., Häring, H.U. and Schleicher, E.D. (2001) Overexpression of glutamine: fructose-6-phosphate-amidotransferase induces transforming growth factor-β1 synthesis in NIH-3T3 fibroblasts. FEBS Lett. 488, 95-99 doi:10.1016/S0014-5793(00)02395-4
35. Buse, M.G. (2005) Hexosamines, insulin resistance, and the complications of diabetes: current status. Am. J. Physiol. Endocrinol. Metab. 290, E1-E8 doi:10.1152/ajpendo.00329.2005
36. Wu, G., Haynes, T.E., Yan, W. and Meininger, C.J. (2001) Presence of glutamine: fructose-6-phosphate amidotransferase for glucosamine-6-phosphate synthesis in endothelial cells: effects of hyperglycaemia and glutamine. Diabetologia 44, 196-202 doi:10.1007/s001250051599
37. Nerlich, A.G., Sauer, U., Kolm-Litty, V., Wagner, E., Koch, M. and Schleicher, E.D. (1998) Expression of glutamine: fructose-6-phosphate amidotransferase in human tissues: evidence for high variability and distinct regulation in diabetes. Diabetes 47, 170-178 doi:10.2337/diab.47.2.170
38. Ishibashi, Y. and Hirabayashi, Y. (2015) AMP-activated protein kinase suppresses biosynthesis of glucosylceramide by reducing intracellular sugar nucleotides. J. Biol. Chem. 290, 18245-18260 doi:10.1074/jbc.M115.658948
39. Li, X., Lu, F., Wang, J.-Z. and Gong, C.-X. (2006) Concurrent alterations of O-GlcNAcylation and phosphorylation of tau in mouse brains during fasting. Eur. J. Neurosci. 23, 2078-2086 doi:10.1111/j.1460-9568.2006.04735.x
40. Liu, F., Iqbal, K., Grundke-Iqbal, I., Hart, G.W. and Gong, C.-X. (2004) O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease. Proc. Natl Acad. Sci. U.S.A. 101, 10804-10809 doi:10.1073/pnas.0400348101
41. Zhu, Y., Shan, X., Yuzwa, S.A. and Vocadlo, D.J. (2014) The emerging link between O-GlcNAc and Alzheimer disease. J. Biol. Chem. 289, 34472-34481 doi:10.1074/jbc.R114.601351
42. Kornfeld, R. (1967) Studies on L-glutamine D-fructose 6-phosphate amidotransferase. I. Feedback inhibition by uridine diphosphate-N-acetylglucosamine. J. Biol. Chem. 242, 3135-3141 PMID:5474877
43. Taylor, R.P., Geisler, T.S., Chambers, J.H. and McClain, D.A. (2009) Up-regulation of O-GlcNAc transferase with glucose deprivation in HepG2 cells is mediated by decreased hexosamine pathway flux. J. Biol. Chem. 284, 3425-3432 doi:10.1074/jbc.M803198200
44. Bullen, J.W., Balsbaugh, J.L., Chanda, D., Shabanowitz, J., Hunt, D.F., Neumann, D. et al. (2014) Cross-talk between two essential nutrient-sensitive enzymes: O-GlcNAc transferase (OGT) and AMP-activated protein kinase (AMPK). J. Biol. Chem. 289, 10592-10606 doi:10.1074/jbc.M113.523068
45. Du, X.L., Edelstein, D., Dimmeler, S., Ju, Q., Sui, C. and Brownlee, M. (2001) Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. J. Clin. Invest. 108, 1341-1348 doi:10.1172/JCI11235
46. Federici, M., Menghini, R., Mauriello, A., Hribal, M.L., Ferrelli, F., Lauro, D. et al. (2002) Insulin-dependent activation of endothelial nitric oxide synthase is impaired by O-linked glycosylation modification of signaling proteins in human coronary endothelial cells. Circulation 106, 466-472 doi:10.1161/01.CIR.0000023043.02648.51
47. Luo, B., Soesanto, Y. and McClain, D.A. (2008) Protein modification by O-linked GlcNAc reduces angiogenesis by inhibiting Akt activity in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 28, 651-657 doi:10.1161/ATVBAHA.107.159533
48. Du, X.-L., Edelstein, D., Rossetti, L., Fantus, I.G., Goldberg, H., Ziyadeh, F. et al. (2000) Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc. Natl Acad. Sci. U.S.A. 97, 12222-12226 doi:10.1073/pnas.97.22.12222
49. Yao, D., Taguchi, T., Matsumura, T., Pestell, R., Edelstein, D., Giardino, I. et al. (2007) High glucose increases angiopoietin-2 transcription in microvascular endothelial cells through methylglyoxal modification of mSin3A. J. Biol. Chem. 282, 31038-31045 doi:10.1074/jbc.M704703200
50. Eberhard, D., Kragl, M. and Lammert, E. (2010) 'Giving and taking': endothelial and beta-cells in the islets of Langerhans. Trends Endocrinol. Metab. 21, 457-463 doi:10.1016/j.tem.2010.03.003
51. Kolluru, G.K., Bir, S.C. and Kevil, C.G. (2012) Endothelial dysfunction and diabetes: effects on angiogenesis, vascular remodeling, and wound healing. Int. J. Vasc. Med. 2012, 30 doi:10.1155/2012/918267
52. Heiss, M., Hellstrom, M., Kalen, M., May, T., Weber, H., Hecker, M. et al. (2015) Endothelial cell spheroids as a versatile tool to study angiogenesis in vitro. FASEB J. 29, 3076-3084 doi:10.1096/fj.14-267633
53. Onat, D., Brillon, D., Colombo, P.C. and Schmidt, A.M. (2011) Human vascular endothelial cells: a model system for studying vascular inflammation in diabetes and atherosclerosis. Curr. Diab. Rep. 11, 193-202 doi:10.1007/s11892-011-0182-2